Abstract
Systolic arterial hypertension is the most common variable of the hypertensive disease and it is mainly concentrated in individuals who are 60 years old and older. At a global level, such population is rapidly growing in every society.
In senior persons, losing weight and lowering sodium consumption helps decreasing Blood pressure (BP). Using antihypertensive medications reduces cardiovascular mortality. In this chapter the management of BP with diuretics is discussed.
Keywords: Arterial hypertension, blood pressure control, diuretics, elderly.
Cardiovascular & Hematological Agents in Medicinal Chemistry
Title:Diuretics in the Treatment of Elderly Hypertensive Patients
Volume: 12 Issue: 3
Author(s): Cesar G. Calvo Vargas
Affiliation:
Keywords: Arterial hypertension, blood pressure control, diuretics, elderly.
Abstract: Systolic arterial hypertension is the most common variable of the hypertensive disease and it is mainly concentrated in individuals who are 60 years old and older. At a global level, such population is rapidly growing in every society.
In senior persons, losing weight and lowering sodium consumption helps decreasing Blood pressure (BP). Using antihypertensive medications reduces cardiovascular mortality. In this chapter the management of BP with diuretics is discussed.
Export Options
About this article
Cite this article as:
Calvo Vargas G. Cesar, Diuretics in the Treatment of Elderly Hypertensive Patients, Cardiovascular & Hematological Agents in Medicinal Chemistry 2014; 12 (3) . https://dx.doi.org/10.2174/1871525713666150310111250
DOI https://dx.doi.org/10.2174/1871525713666150310111250 |
Print ISSN 1871-5257 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6182 |
Call for Papers in Thematic Issues
Medicinal Plants with Beneficial Properties on Diabetes and Hypertension
Diabetes and hypertension are real scourges of the 21st century. It is imperative to act in order to find innovative solutions to this problem. Taking medications such as hypoglycemic and antihypertensive drugs may aggravate certain underlying comorbidities, such as chronic kidney disease and cardiovascular disease. This significant drawback therefore requires ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The “Neurocentric” Approach to Essential Hypertension: How Reliable is the Paradigm of Hyperkinetic Hypertension? A Focus on the Sympathetic Nervous System Dysregulation in Essential Hypertensive Patients with Elevated Resting Heart Rate
Current Pharmaceutical Design The Effectiveness of Different Treatment Modalities for the Management of Ocular Injuries Following Sulfur Mustard Exposure
Letters in Drug Design & Discovery The Cardiovascular Protective Effects of Chrysin: A Narrative Review on Experimental Researches
Cardiovascular & Hematological Agents in Medicinal Chemistry Current Perspectives on Hypertension in Asian Indians
Current Hypertension Reviews Antagonism of Endothelin (ETA and ETB) Receptors During Renovascular Hypertension-Induced Vascular Dementia Improves Cognition
Current Neurovascular Research Statins, Mevalonate Pathway and its Intermediate Products in Placental Development and Preeclampsia
Current Molecular Pharmacology Preventive Role of Resveratrol Against Inflammatory Cytokines and Related Diseases
Current Pharmaceutical Design Patients with Rheumatic Diseases Overlooked during COVID-19 Pandemic: How are They Doing and Behaving?
Current Rheumatology Reviews A Review on the Development in the Field of NIDDM based Thiazolidinedione PPARγ Agonists
Mini-Reviews in Medicinal Chemistry Novel Therapeutics for Diabetic Micro- and Macrovascular Complications
Current Medicinal Chemistry The Effects of Lipid-Regulating Therapy on Haemostatic Parameters
Current Pharmaceutical Design Non-coding RNAs and Hypertension–Unveiling Unexpected Mechanisms of Hypertension by the Dark Matter of the Genome
Current Hypertension Reviews Origin of Chiral Pharmacology Stereochemistry in Metalloprotease Inhibition
Mini-Reviews in Medicinal Chemistry Post-Translational Protein Modifications of Rare and Unconventional Types: Implications in Functions and Diseases
Current Medicinal Chemistry Patent Selections:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Determinants of Left Ventricular Hypertrophy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Determinants of Perceived Severity of Hypertension and Drug-Compliance in Hypertensive Patients
Cardiovascular & Hematological Disorders-Drug Targets The Adipose Tissue as a Source of Vasoactive Factors
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Insulin Resistance and the Renin-Angiotensin-Aldosterone System in Metabolic Syndrome and Obesity-Related Hypertension
Current Hypertension Reviews Erectile Dysfunction and Coronary Artery Disease in Patients with Diabetes
Current Diabetes Reviews